Gujarat Kidney and Super Speciality IPO

Incorporated in 2019, Gujarat Kidney & Super Speciality Limited operates a chain of multispeciality hospitals across Gujarat. The company focuses on secondary and tertiary healthcare services, with a strong presence in renal sciences and urology. It manages seven hospitals and four pharmacies with a total operational bed capacity of 340 beds. Backed by experienced medical professionals, the company delivers specialised surgical and critical care services while maintaining consistent operational growth across locations.

Gujarat Kidney & Super Speciality Limited IPO Overview

Gujarat Kidney & Super Speciality Limited IPO is a bookbuilding issue of ₹250.80 crore, comprising entirely a fresh issue of 2.20 crore equity shares. The IPO opens for subscription on 22 December 2025 and closes on 24 December 2025. The price band is fixed at ₹108 to ₹114 per share with a lot size of 128 shares. The issue will list on BSE and NSE, with Nirbhay Capital Services Pvt. Ltd. acting as the book running lead manager and MUFG Intime India Pvt. Ltd. as the registrar.

Gujarat Kidney & Super Speciality Limited IPO Details

Particulars	Details
IPO Date	22 December 2025 to 24 December 2025
Listing Date	30 December 2025
Face Value	₹2 per share
Issue Price Band	₹108 to ₹114 per share
Lot Size	128 Shares
Total Issue Size	2,20,00,000 shares (₹250.80 Cr)
Fresh Issue	2,20,00,000 shares (₹250.80 Cr)
Offer for Sale	NA
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	5,68,43,250 shares
Share Holding Post Issue	7,88,43,250 shares

Gujarat Kidney & Super Speciality Limited IPO Reservation

Investor Category	Shares Offered
QIB	Not less than 75% of the Net Issue
Retail	Not more than 10% of the Net Issue
NII (HNI)	Not more than 15% of the Net Issue

Gujarat Kidney & Super Speciality Limited IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	1	128	₹14,592
Retail (Max)	13	1,664	₹1,89,696
S-HNI (Min)	14	1,792	₹2,04,288
B-HNI (Min)	69	8,832	₹10,06,848

Gujarat Kidney & Super Speciality Limited IPO Promoter Holding

Shareholding Status	Percentage
Pre-Issue	99.10%
Post-Issue	71.45%

Gujarat Kidney & Super Speciality Limited IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	₹1.85
Price/Earnings (P/E) Ratio	61.62x
Return on Net Worth (RoNW)	36.61%
Net Asset Value (NAV)	₹5.04
Return on Equity	36.61%
Return on Capital Employed (ROCE)	37.65%
EBITDA Margin	41.12%
PAT Margin	23.61%
Debt to Equity Ratio	0.15

Objectives of the Proceeds

• Acquisition of Parekhs Hospital, Ahmedabad – ₹77.00 Cr

• Part-payment for Ashwini Medical Centre acquisition – ₹12.40 Cr

• Capital expenditure for new Vadodara hospital – ₹30.10 Cr

• Purchase of advanced robotic medical equipment – ₹6.83 Cr

• Repayment or prepayment of secured borrowings – ₹1.20 Cr

• Inorganic growth initiatives and general corporate purposes

Key Financials (in ₹ crore)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	55.34	20.53	3.87
Revenue	40.40	5.48	0.00
Profit After Tax	9.50	1.71	-0.01
Reserves and Surplus	14.57	10.60	0.17
Total Borrowings	3.88	1.94	NA